Atmus Filtration Technologies Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Atmus Filtration Technologies Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	1,439	1,562	1,628	1,670	1,764
Cost of revenue	1,090	1,203	1,195	1,208	1,266
Gross profit	349	359	433	462	498
Research and development	42	38.6	42.5	40.6	40.7
Selling, general and administrative	126	140	175	188	184
Operating income	214	204	248	266	299
Interest expense	0.8	0.7	25.8	40.6	33.4
Other non-operating income	3.9	8.8	3.8	9.2	0.6
Pre-tax income	217	212	226	235	266
Income tax	46.5	41.6	55.1	49.2	58.8
Net income	170	170	171	186	207
EBITDA	235	226	270	291	329
EPS, basic	2.04	2.05	2.06	2.23	2.52
EPS, diluted	2.04	2.05	2.05	2.22	2.50
Shares, basic (weighted)	83.3	83.3	83.3	83.2	82.2
Shares, diluted (weighted)	83.3	83.3	83.4	83.6	82.8
Dividend per share				0.10	0.21

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents	0	0	168	184	236
Receivables		174	247	254	275
Inventory		245	250	267	282
Other current assets		19.3	28.2	49.9	53.6
Total current assets		500	693	755	892
Property, plant and equipment		148	175	186	197
Lease right-of-use assets		32.4	24.8	37.3	39.5
Goodwill		84.7	84.7	84.7	84.7
Intangible assets					0
Other non-current assets		57	51.5	79.5	87.3
Total assets		867	1,089	1,190	1,351
Accounts payable		146	237	193	202
Accrued liabilities		18.2	41.8	37.2	37.9
Short-term debt		0	7.5	22.5	30
Total current liabilities		331	375	345	368
Long-term debt		0	593	570	540
Lease liabilities		23.2	18.5	26.6	23.8
Other non-current liabilities		71.2	31.8	40.7	56
Total liabilities		412	1,008	963	972
Total debt		0	600	593	570
Paid-in capital		0	49.7	61.9	72.7
Retained earnings		0	87.2	265	455
Treasury stock			0	-20	-80.7
Other comprehensive income		-55.8	-56.2	-79	-68.1
Shareholders' equity	428	456	80.7	227	379
Total equity	428	456	80.7	227	379
Total liabilities and equity		867	1,089	1,190	1,351
Shares outstanding			83.3

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	170	170	171	186	207
Depreciation and amortization	21.6	21.6	21.5	24.8	30
Stock-based compensation	0	0	7.2	11.9	12.4
Deferred income tax	-2.7	-12.7	-10	-7.7	18.7
Change in receivables	0.2	-18.3	-10.1	-16.8	-55.2
Change in inventory	-43.5	-9.7	-4.3	-25.4	-7.1
Change in payables	20.5	18.5	4.4	-39.3	-2.3
Cash from operations	210	166	189	105	203
Capital expenditures	-33.4	-37.5	-45.8	-48.6	-53.9
Cash from investing	-33.4	-37.5	-45.8	-48.6	-53.9
Debt issued	0	0	650	0	0
Debt repaid	0	0	-50	-7.5	-22.5
Share buybacks		0	0	-20	-60.7
Dividends paid		0	0	-8.3	-17.3
Cash from financing	-177	-128	24.8	-35.8	-102
Exchange rate effect		0	0	-4.7	5
Net change in cash	0	0	168	16.3	52.1
Free cash flow	177	128	143	56.8	149
Income taxes paid	17.6	20.3	41.3	66.9	43.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $44.71 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.8%	Gross profit / revenue.
Operating margin	17.2%	Operating income / revenue.
EBITDA margin	19.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.6%	Pre-tax income / revenue.
Net margin	11.3%	Net income / revenue.
FCF margin	10.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.9%	Cash from operations / revenue.
Effective tax rate	22.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	47.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.4%	Net income / average total assets.
Return on invested capital (ROIC)	21.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.0%	Research and development expense / revenue.
SG&A / revenue	10.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	2.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	7.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	11.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	12.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	13.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	13.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	13.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	11.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	12.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	6.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	92.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	162.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	5.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share growth, 1y	110.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	66.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	13.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	15.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	-1.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.65x	Current assets / current liabilities.
Quick ratio	1.58x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.71x	(Cash + short-term investments) / current liabilities.
Debt / equity	2.20x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	52.9%	Total debt / total assets.
Liabilities / assets	75.9%	Total liabilities / total assets.
Net debt	$741.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.03x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.36x	Operating income / interest expense.
Working capital	$601.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	27.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$57.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.00x	Revenue / average total assets.
Fixed asset turnover	8.96x	Revenue / average property, plant and equipment.
Inventory turnover	4.55x	Cost of revenue / average inventory.
Days inventory	80 days	365 x average inventory / cost of revenue.
Receivables turnover	5.99x	Revenue / average receivables.
Days sales outstanding	61 days	365 x average receivables / revenue.
Days payables	60 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	81 days	Days inventory + days sales outstanding - days payables.
FCF conversion	88.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	22.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$23.17	Revenue / diluted weighted shares.
FCF per share	$2.32	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.99	Cash from operations / diluted weighted shares.
Book value per share	$5.55	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.70	Tangible book value / shares outstanding.
Cash per share	$3.16	(Cash + short-term investments) / shares outstanding.
Payout ratio	8.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	9.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	26.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.65B	Share price x shares outstanding.
Enterprise value	$4.39B	Market cap + total debt - cash - short-term investments.
P/E	17.0x	Market cap / net income. Only when net income is positive.
P/S	1.92x	Market cap / revenue.
P/B	8.02x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	19.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.9x	Market cap / cash from operations, when positive.
EV/Sales	2.31x	Enterprise value / revenue.
EV/EBIT	13.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.2%	Free cash flow / market cap.
Earnings yield	5.9%	Net income / market cap (the inverse of P/E).
Dividend yield	0.5%	Dividends paid over the period / market cap.
Shareholder yield	1.9%	(Dividends paid + share buybacks) / market cap.
PEG	2.48x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Atmus Filtration Technologies Inc.'s revenue in fiscal 2025?

Atmus Filtration Technologies Inc. reported revenue of $1.76B for fiscal 2025, 5.7% higher than the year before.

Was Atmus Filtration Technologies Inc. profitable in fiscal 2025?

Yes. Net income was $207.4M, a net margin of 11.8%.

How much free cash flow did Atmus Filtration Technologies Inc. generate in fiscal 2025?

Cash from operations of $202.7M minus capital expenditures of $53.9M left free cash flow of $148.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Atmus Filtration Technologies Inc.